Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

NCT00708812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG: Endostar(Recombinant Human Endostatin Injection)
DRUG: paclitaxel-carboplatin

Sponsor

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd